These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9399976)
1. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. Bol CJJG ; Danhof M; Stanski DR; Mandema JW J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976 [TBL] [Abstract][Full Text] [Related]
2. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. Bol CJ; Vogelaar JP; Mandema JW J Pharmacol Exp Ther; 1999 Oct; 291(1):153-60. PubMed ID: 10490899 [TBL] [Abstract][Full Text] [Related]
3. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. Bol CJ; Vogelaar JP; Tang JP; Mandema JW J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Doze V; Chen BX; Li Z; Maze M Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279 [TBL] [Abstract][Full Text] [Related]
5. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat. Seidel WF; Maze M; Dement WC; Edgar DM J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559 [TBL] [Abstract][Full Text] [Related]
6. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation. Cox EH; Kuipers JA; Danhof M Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968 [TBL] [Abstract][Full Text] [Related]
8. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine. Horváth G; Kovács M; Szikszay M; Benedek G Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat. Mathôt RA; van Schaick EA; Langemeijer MW; Soudijn W; Breimer DD; Ijzerman AP; Danhof M J Pharmacol Exp Ther; 1994 Feb; 268(2):616-24. PubMed ID: 8113972 [TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of preanaesthetic intramuscular medetomidine and dexmedetomidine in domestic sheep. Kastner SB; Boller M; Kutter A; Akens MK; Bettschart-Wolfensberger R Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):409-13. PubMed ID: 11721587 [TBL] [Abstract][Full Text] [Related]
11. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine. Reid K; Guo TZ; Davies MF; Maze M J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968 [TBL] [Abstract][Full Text] [Related]
12. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy. Mandema JW; Kuck MT; Danhof M J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat. Mandema JW; Wada DR J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477 [TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine on respiratory mechanics and control of breathing in normal rats. Fernandes FC; Ferreira HC; Cagido VR; Carvalho GM; Pereira LS; Faffe DS; Zin WA; Rocco PR Respir Physiol Neurobiol; 2006 Dec; 154(3):342-50. PubMed ID: 16527548 [TBL] [Abstract][Full Text] [Related]
16. Cardiorespiratory and minimum alveolar concentration sparing effects of a continuous intravenous infusion of dexmedetomidine in halothane or isoflurane-anaesthetized rats. Rioja E; Santos M; Martínez Taboada F; Ibancovichi JA; Tendillo FJ Lab Anim; 2006 Jan; 40(1):9-15. PubMed ID: 16460585 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat. Correa-Sales C; Nacif-Coelho C; Reid K; Maze M J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568 [TBL] [Abstract][Full Text] [Related]
18. Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures. Mandema JW; Heijligers-Feijen CD; Tukker E; De Boer AG; Danhof M J Pharmacol Exp Ther; 1992 Apr; 261(1):88-95. PubMed ID: 1560387 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects on respiratory carbon dioxide response, arterial blood pressure, and heart rate of dexmedetomidine, propofol, and midazolam in sevoflurane-anesthetized rabbits. Chang C; Uchiyama A; Ma L; Mashimo T; Fujino Y Anesth Analg; 2009 Jul; 109(1):84-9. PubMed ID: 19535698 [TBL] [Abstract][Full Text] [Related]
20. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine. Zornow MH Neuropharmacology; 1991 Oct; 30(10):1065-71. PubMed ID: 1684646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]